Related Experiment Videos
Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8
Keith B Gorden1, Kevin S Gorski, Sheila J Gibson
13M Pharmaceuticals, St. Paul, MN 55144, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|January 22, 2005
Summary
Toll-like receptor 7 (TLR7) and Toll-like receptor 8 (TLR8) agonists activate different human immune cells. TLR7 agonists activate plasmacytoid dendritic cells, while TLR8 agonists activate myeloid cells, leading to distinct immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are crucial for innate immunity.
- TLR7 and TLR8 are structurally similar but their distinct functions remain unclear.
- Lack of TLR8-selective agonists has limited research.
Purpose of the Study:
- To investigate the cell-specific activation profiles of TLR7 and TLR8 agonists.
- To compare the cytokine and chemokine induction patterns of TLR7 and TLR8 agonists.
Main Methods:
- Utilized TLR7- and TLR8-selective agonists.
- Assessed activation of purified human innate immune cells.
- Measured induction of cytokines and chemokines (e.g., IFN-alpha, TNF-alpha).
Main Results:
- TLR7 agonists selectively activated plasmacytoid dendritic cells and monocytes.
- TLR8 agonists activated myeloid dendritic cells, monocytes, and monocyte-derived dendritic cells.
- TLR7 agonists induced higher levels of IFN-alpha and IFN-regulated chemokines.
- TLR8 agonists induced higher levels of pro-inflammatory cytokines and chemokines.
Conclusions:
- TLR7 and TLR8 agonists exhibit distinct target cell specificities.
- Differential cytokine and chemokine induction profiles highlight unique roles for TLR7 and TLR8 in immune responses.